BOT:AU Botanix Pharmaceuticals Ltd

AUD 0.30 0.00 0
Icon

Botanix Pharmaceuticals Ltd (BOT:AU) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | AU
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

AUD 0.3

0.00 (0.00)%

AUD 0.46B

2.80M

N/A

N/A

Icon

BOT:AU

Botanix Pharmaceuticals Ltd (AUD)
COMMON STOCK | AU
AUD 0.30
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

AUD 0.46B

N/A

AUD 0.30

Botanix Pharmaceuticals Ltd (BOT:AU) Stock Forecast

N/A

Based on the Botanix Pharmaceuticals Ltd stock forecast from 0 analysts, the average analyst target price for Botanix Pharmaceuticals Ltd is not available over the next 12 months. Botanix Pharmaceuticals Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Botanix Pharmaceuticals Ltd is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Botanix Pharmaceuticals Ltd’s stock price was AUD 0.3. Botanix Pharmaceuticals Ltd’s stock price has changed by +11.11% over the past week, +42.86% over the past month and +244.83% over the last year.

No recent analyst target price found for Botanix Pharmaceuticals Ltd
No recent average analyst rating found for Botanix Pharmaceuticals Ltd

Company Overview Botanix Pharmaceuticals Ltd

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a dru...Read More

D2, 661 Newcastle Street, Leederville, WA, Australia, 6007

0

June

AUD

Australia

Adjusted Closing Price for Botanix Pharmaceuticals Ltd (BOT:AU)

Loading...

Unadjusted Closing Price for Botanix Pharmaceuticals Ltd (BOT:AU)

Loading...

Share Trading Volume for Botanix Pharmaceuticals Ltd Shares

Loading...

Compare Performance of Botanix Pharmaceuticals Ltd Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BOT:AU

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Botanix Pharmaceuticals Ltd (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CSL:AU
CSL Ltd 0.00 (0.00%) AUD135.76B 36.48 34.93

ETFs Containing BOT

Symbol Name BOT's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Botanix Pharmaceuticals Ltd (BOT:AU) Stock

Stock Target Advisor's fundamental analysis for Botanix Pharmaceuticals Ltd's stock is Slightly Bearish.

Unfortunately we do not have enough data on BOT:AU's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BOT:AU's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BOT:AU's stock to indicate if its overvalued.

The last closing price of BOT:AU's stock was AUD 0.30.

The most recent market capitalization for BOT:AU is AUD 0.46B.

Unfortunately we do not have enough analyst data on BOT:AU's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Botanix Pharmaceuticals Ltd's stock.

As per our most recent records Botanix Pharmaceuticals Ltd has 0 Employees.

Botanix Pharmaceuticals Ltd's registered address is D2, 661 Newcastle Street, Leederville, WA, Australia, 6007. You can get more information about it from Botanix Pharmaceuticals Ltd's website at https://www.botanixpharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...